NVCR logo

NVCR

NovoCure Limited

$13.09
+$0.40(+3.15%)
46
Overall
60
Value
33
Tech
--
Quality
Market Cap
$1.42B
Volume
2.68M
52W Range
$10.87 - $34.13
Target Price
$27.19
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$33.1M$82.9M$177.0M$248.1M$351.3M$494.4M$535.0M$537.8M$509.3M$605.2M
Total Revenue
$33.1M$82.9M$177.0M$248.1M$351.3M$494.4M$535.0M$537.8M$509.3M$605.2M
COST OF GOODS SOLD
Cost of Revenue
$-20.6M$-39.9M$-55.6M$-80.0M$310.0K$616.0K$1.0M$114.9M$128.3M$137.2M
GROSS PROFIT
Gross Profit
$12.5M$36.6M$121.4M$168.0M$262.7M$387.9M$420.2M$423.0M$381.1M$468.0M
OPERATING EXPENSES
Operating Expenses
$-116.5M$-151.9M$-160.7M$-201.7M$263.6M$357.5M$464.5M$512.5M$613.9M$638.5M
Research & Development
$43.7M$41.5M$38.1M$50.6M$79.0M$132.0M$316.2M$206.1M$223.1M$209.6M
Research Expense
$43.7M$41.5M$38.1M$50.6M$79.0M$132.0M$201.3M$206.1M$223.1M$209.6M
Selling, General & Administrative
$72.7M$110.5M$122.6M$151.1M$184.6M$225.5M$263.2M$306.4M$390.9M$428.9M
Selling & Marketing Expenses
$38.9M$59.4M$63.5M$77.7M$96.7M$118.0M$137.1M$173.7M$226.8M$239.1M
General & Administrative Expenses
$33.9M$51.0M$59.1M$73.5M$87.9M$107.4M$126.1M$132.8M$164.1M$189.8M
Salaries & Wages
$-11.9M$-21.4M$-27.1M$-39.8M$984.0K$1.6M$1.5M$2.1M$115.6M--
Depreciation & Amortization
$-1.3M$-1.7M$-2.0M$-2.0M$2.1M$2.6M$2.8M$114.9M$3.9M$6.2M
Depreciation & Amortization
$-1.3M$-1.7M$-2.0M$-2.0M$2.1M$2.6M$2.8M$114.9M$3.9M--
Amortization
$-579.0K$-1.4M$-2.3M$-4.3M$-494.0K$5.9M$4.4M$4.3M$4.6M$4.0M
Other Operating Expenses
$-848.0K$-1.1M$700.0K$87.0K$1.9M$6.0M$7.3M$-5.9M$9.3M--
OPERATING INCOME
Operating income
$-104.0M$-115.3M$-39.3M$-33.7M$-914.0K$30.4M$-44.3M$-89.5M$-232.9M$-170.5M
EBITDA
$-106.9M$-123.0M$-52.3M$-52.8M$5.4M$44.8M$-38.4M$-67.9M$-198.9M$-135.2M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$-3.2M$-7.3M$-11.7M$-16.9M$7.9M$17.6M$3.4M$3.3M$4.9M$10.3M
Intinc
$84.0K$659.0K$1.1M$2.7M$4.4M$1.8M$-7.7M$7.7M$41.1M--
Net Non-Operating Interest Income/Expense
$-3.2M$-6.1M$-9.2M$-12.3M$-7.9M$-12.3M$-7.7M$-11.2M$41.1M$39.3M
Other Income/Expense
----------$-1.3M$-306.0K$-3.5M$-26.4M$-28.3M
Other Special Charges
----------$1.3M$306.0K$17.8M$26.4M--
SPECIAL ITEMS
Restructring And Mn A Income
$-356.0K$-430.0K$-506.0K$-526.0K$88.6M$1.1M$1.5M$1.6M$6.2M--
Special Income Charges
$356.0K$430.0K$506.0K$526.0K$-88.6M$-1.1M$-2.1M$-2.5M$-6.7M$-3.2M
Impairment of Capital Assets
------------$649.0K$955.0K$493.0K--
PRE-TAX INCOME
EBIT
$-110.4M$-128.8M$-60.2M$-62.9M$-914.0K$35.7M$-48.6M$-78.5M$-186.8M$-120.8M
Pre-Tax Income
$-107.1M$-121.5M$-48.5M$-45.9M$-8.8M$18.1M$-52.1M$-81.8M$-191.7M$-131.2M
INCOME TAX
Tax Provision
$4.4M$10.4M$13.2M$17.6M$-1.6M$-1.7M$6.3M$10.7M$15.3M$37.5M
NET INCOME
Net Income
$-111.6M$-131.8M$-61.7M$-63.6M$-7.2M$19.8M$-58.4M$-92.5M$-207.0M$-168.6M
Net Income (Continuing Operations)
$-111.6M$-131.8M$-61.7M$-63.6M$-7.2M$19.8M$-58.4M$-92.5M$-207.0M$-168.6M
Net Income (Discontinued Operations)
$-111.6M$-131.8M$-61.7M$-63.6M$-7.2M$19.8M$-58.4M$-92.5M$-207.0M$-168.6M
Net Income (Common Stockholders)
$-111.6M$-131.8M$-61.7M$-63.6M$-7.2M$19.8M$-58.4M$-92.5M$-207.0M$-168.6M
TOTALS
Total Expenses
$-137.1M$-191.8M$-216.4M$-281.7M$263.9M$358.1M$465.5M$627.4M$742.2M$775.7M
SHARE & EPS DATA
Average Shares Outstanding
$30.4M$85.6M$88.5M$91.8M$97.2M$100.9M$103.4M$104.7M$106.4M$107.8M
Average Shares Outstanding (Diluted)
$30.4M$85.6M$88.1M$92.1M$107.9M$108.9M$103.4M$104.7M$106.4M$107.8M
Shares Outstanding
$84.4M$87.1M$89.9M$95.0M$99.6M$102.4M$104.4M$105.5M$107.1M$109.9M
Basic EPS
--------$0.04$0.20$-0.56$-0.88$-1.95$-1.56
Basic EPS (Continuing Operations)
--------------$-0.88$-1.95$-1.56
Diluted EPS
$-3.67$-1.54$-0.70$-0.69$-0.07$0.18$-0.56$-0.88$-1.95$-1.56
Diluted EPS (Continuing Operations)
--------------$-0.88$-1.95$-1.56
OTHER METRICS
Acquisition Expense
--------------$114.9M----
Development Expense
------------$114.9M------
Excise Taxes
$-1.5M$-972.0K$-1.2M$-1.7M------------
Loss And Loss Adjustment Expected Incurred
----------$106.5M--------
Other Gand A
$33.9M$51.0M$59.1M$73.5M$87.9M$107.4M$126.1M$132.8M$164.1M$189.8M
Other Taxes
$-818.0K$-867.0K----------------
Rent And Landing Fees
$33.9M$51.0M$59.1M$73.5M$87.9M$107.4M$126.1M------
Selling Expense
$38.9M$59.4M$63.5M$77.7M$96.7M$118.0M$137.1M------
Restruct
$-356.0K$-430.0K$-506.0K$-526.0K$88.6M$1.1M$1.5M$1.6M$6.2M--

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2NVCR$13.09+3.2%2.68M
3
4
5
6

Get NovoCure Limited Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.